↓ Skip to main content

Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial

Overview of attention for article published in Trials, August 2017
Altmetric Badge

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
122 Mendeley